In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rottapharm SPA

Division of Mylan NV
www.rotta.com

Latest From Rottapharm SPA

Deals Shaping The Medical Industry, March 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2016.

BioPharmaceutical Medical Device

Deals Shaping the Medical Industry, February 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2016.

BioPharmaceutical Medical Device

Which Way Now For Mid-Sized European Pharmas?

Compared with their top 20 European peers and with similarly sized companies in the US, many mid-sized European pharmas are struggling. IMS Health analyzes the predicament these companies find themselves in and outlines what they need to do to avoid being caught in an evolutionary backwater.

BioPharmaceutical Europe

Nutraceuticals - At The Cusp Of A Global Surge?

Nutraceuticals is set to be the next big business segment, for the global health industry as well as Indian drug firms, according to a recent analysis by MP Advisors. But for India to emerge as a meaningful contender, government regulations will need to be streamlined.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Rottapharm
  • Rotta Research SPA
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Parent & Subsidiaries
  • Mylan NV
  • Senior Management
  • Luca Rovati, CEO
    Lucio Rovati, MD, CSO
  • Contact Info
  • Rottapharm SPA
    Phone: (39) 039.7390.1
    Via Valosa Di Sopra, 9
    Monza, 20900
    Italy
Advertisement
Advertisement
UsernamePublicRestriction

Register